CATHERINE MCNAMARA: Open Payments
NPI 1144779471 · TRENTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$824 in 45 payments from 19 companies in 2025. Trend: 2023 $551 · 2024 $1,057 · 2025 $824
Food & beverage: $824
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 11 | $238 |
| ABBVIE INC. | 6 | $99 |
| Novo Nordisk Inc | 4 | $77 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $49 |
| PFIZER INC. | 2 | $41 |
| Exact Sciences Corporation | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Bausch Health US, LLC | 2 | $36 |
| Currax Pharmaceuticals LLC | 2 | $31 |
| Amgen Inc. | 2 | $30 |
Products named: Auvelity, VRAYLAR, Wegovy, REXULTI, XIFAXAN, Cologuard Collection Kit, APLENZIN, Sunosi.
Industry payments across NJ — which companies pay providers there.
